News
American Express Reports Third-Quarter Revenue of $8.8 Billion and Earnings Per Share Of $1.30
American Express Company (NYSE: AXP) today reported third-quarter net income of $1.1 billion, or $1.30 per share, compared with net income of $1.8 billion, or $2.08 per share, a year ago.
![shopDisney.com|Disney Store Unveil the Top 15 Toys for the 2020 Holiday Season](/assets/news/news18-f135f6c168ef56d2b112890081403b0a310104acfadbf4a8f72634bd390e98ac.png)
shopDisney.com|Disney Store Unveil the Top 15 Toys for the 2020 Holiday Season
Today, shopDisney.com|Disney store revealed its 2020 Top 15 Holiday Toys list. This marks the third year the retailer is sharing a list of holiday must-haves for Disney fans, families and
![Data From Pfizer’s Adult and Pediatric Clinical Trial Programs for 20-Valent Pneumococcal Conjugate Vaccine Presented at IDWeek 2020http://www.flickr.com/photos/w0ahitslo/6955091156/sizes/z/in/photostream/: All rights reserved by Queen Beuaroo](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBZHc9IiwiZXhwIjpudWxsLCJwdXIiOiJibG9iX2lkIn19--be1a2af5756eaa0acf5414ead3504a7e3ad45f8a/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/Pfizer.jpg?locale=us)
Data From Pfizer’s Adult and Pediatric Clinical Trial Programs for 20-Valent Pneumococcal Conjugate Vaccine Presented at IDWeek 2020
Pfizer Inc. (NYSE:PFE) today announced the full analysis from one of its Phase 3 studies (NCT03760146), which evaluated the safety and immunogenicity of its 20-valent pneumococcal conjugate vaccine
![Intel nach Verkauf der NAND-Sparte: Wie geht es nun weiter?](/assets/news/news18-f135f6c168ef56d2b112890081403b0a310104acfadbf4a8f72634bd390e98ac.png)
Intel nach Verkauf der NAND-Sparte: Wie geht es nun weiter?
Wie heute Nacht bekanntwurde, hat der US-Chipgigant Intel (WKN: 855681) sein Geschäft mit NAND-Flash-Speicherchips an die südkoreanische SK Hynix veräußert. Der Kaufpreis hierfür beträgt neun
IBM Reports 2020 Third-Quarter Results
IBM (NYSE: IBM) today announced third-quarter 2020 earnings results.
“The strong performance of our cloud business, led by Red Hat, underscores the growing client adoption of our open hybrid
American Express Declares Dividends on Series B and Series C Preferred Stock
American Express Company (NYSE: AXP) has declared the following dividends on the Company’s Series B and C Preferred Shares:
-
A quarterly dividend on the Company’s 5.200% Fixed Rate / Floating
![American Express to Host Ninth Annual “Business Class LIVE: Summit for Success” for Small Businesses](/assets/news/news16-82a218458f0e15ae617f9186b258dfd3add112716106c6ee3cbb48563ccdef52.png)
American Express to Host Ninth Annual “Business Class LIVE: Summit for Success” for Small Businesses
For more than 60 years, American Express (NYSE: AXP) has been committed to supporting the small business community. American Express is continuing that commitment with a unique virtual experience
American Express Partners With GlobalGiving to Enable Its Colleagues Around the World to Back Their Communities
To enable its colleagues around the world to back causes that matter to them, American Express (NYSE: AXP) today announced a partnership with GlobalGiving, a one-stop solution for charitable
![PENELOPE-B Trial of IBRANCE® (palbociclib) in Early Breast Cancer Did Not Meet Primary Endpointhttp://www.flickr.com/photos/w0ahitslo/6955091156/sizes/z/in/photostream/: All rights reserved by Queen Beuaroo](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBZHc9IiwiZXhwIjpudWxsLCJwdXIiOiJibG9iX2lkIn19--be1a2af5756eaa0acf5414ead3504a7e3ad45f8a/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/Pfizer.jpg?locale=us)
PENELOPE-B Trial of IBRANCE® (palbociclib) in Early Breast Cancer Did Not Meet Primary Endpoint
The German Breast Group (GBG) and Pfizer Inc. (NYSE: PFE) today announced that the collaborative Phase 3 PENELOPE-B trial did not meet the primary endpoint of improved invasive disease-free
![Pfizer Announces Positive Phase 3 Top-line Results for Once-Weekly Investigational Long-Acting Human Growth Hormone to Treat Children with Growth Hormone Deficiencyhttp://www.flickr.com/photos/w0ahitslo/6955091156/sizes/z/in/photostream/: All rights reserved by Queen Beuaroo](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBZHc9IiwiZXhwIjpudWxsLCJwdXIiOiJibG9iX2lkIn19--be1a2af5756eaa0acf5414ead3504a7e3ad45f8a/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/Pfizer.jpg?locale=us)
Pfizer Announces Positive Phase 3 Top-line Results for Once-Weekly Investigational Long-Acting Human Growth Hormone to Treat Children with Growth Hormone Deficiency
Pfizer Inc. (NYSE: PFE) and OPKO Health Inc. (NASDAQ: OPK) announced today that C0311002, a Phase 3, randomized, multicenter, open-label, crossover study evaluating somatrogon dosed once-weekly in
![Pfizer and Sangamo Dose First Participant in Phase 3 Study Evaluating Hemophilia A Gene Therapy Treatmenthttp://www.flickr.com/photos/w0ahitslo/6955091156/sizes/z/in/photostream/: All rights reserved by Queen Beuaroo](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBZHc9IiwiZXhwIjpudWxsLCJwdXIiOiJibG9iX2lkIn19--be1a2af5756eaa0acf5414ead3504a7e3ad45f8a/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/Pfizer.jpg?locale=us)
Pfizer and Sangamo Dose First Participant in Phase 3 Study Evaluating Hemophilia A Gene Therapy Treatment
Pfizer Inc. (NYSE: PFE) and Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicines company, today announced that the first participant has been dosed in the Phase 3 AFFINE study of
![Advisory: Chevron Corporation's 3Q 2020 Earnings Conference Call and Webcasthttp://intelligents.wpengine.netdna-cdn.com/wp-content/uploads/2011/04/chevron-corporation-logo.png: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/11090/chevron-corporation-logo.png](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBZWs9IiwiZXhwIjpudWxsLCJwdXIiOiJibG9iX2lkIn19--810d4ee3ee1f323ecd07b89039e6a5fb12ed54d0/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/chevron-corporation-logo.png?locale=us)
Advisory: Chevron Corporation's 3Q 2020 Earnings Conference Call and Webcast
Chevron Corporation (NYSE: CVX), one of the world’s leading energy companies, will hold its quarterly earnings conference call on Friday, October 30, 2020 at 11:00 a.m. ET (8:00 a.m. PT).
![Chevron Completes Acquisition of Noble Energyhttp://intelligents.wpengine.netdna-cdn.com/wp-content/uploads/2011/04/chevron-corporation-logo.png: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/11090/chevron-corporation-logo.png](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBZWs9IiwiZXhwIjpudWxsLCJwdXIiOiJibG9iX2lkIn19--810d4ee3ee1f323ecd07b89039e6a5fb12ed54d0/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/chevron-corporation-logo.png?locale=us)
Chevron Completes Acquisition of Noble Energy
Chevron Corporation (NYSE: CVX) announced today that its acquisition of Noble Energy, Inc. (NASDAQ: NBL) has been completed following approval by Noble Energy shareholders.
“We are pleased to
![American Express Opens Flagship Centurion® Lounge at New York’s John F. Kennedy Airport](/assets/news/news3-3816cd3656012f9a06bae00ff06108b383643da017a8247fff474f84ea8a7c5a.png)
American Express Opens Flagship Centurion® Lounge at New York’s John F. Kennedy Airport
Today, American Express (NYSE: AXP) announced its 13th Centurion Lounge will open at John F. Kennedy Airport (JFK)’s Terminal 4 in the coming days. With more than 15,000 square feet, the new space
![Pfizer Receives FDA Fast Track Designation for Duchenne Muscular Dystrophy Investigational Gene Therapyhttp://www.flickr.com/photos/w0ahitslo/6955091156/sizes/z/in/photostream/: All rights reserved by Queen Beuaroo](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBZHc9IiwiZXhwIjpudWxsLCJwdXIiOiJibG9iX2lkIn19--be1a2af5756eaa0acf5414ead3504a7e3ad45f8a/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/Pfizer.jpg?locale=us)
Pfizer Receives FDA Fast Track Designation for Duchenne Muscular Dystrophy Investigational Gene Therapy
Pfizer Inc. (NYSE: PFE) today announced that its investigational gene therapy candidate (PF-06939926) being developed to treat Duchenne muscular dystrophy (DMD) received Fast Track designation from
American Express Publishes its First Environmental, Social And Governance Report
American Express (NYSE: AXP) today announced the release of its first Environmental, Social and Governance (ESG) report, which outlines the company’s approach to responsibly back its colleagues
American Express Declares Regular Quarterly Dividend
The Board of Directors of American Express Company (NYSE: AXP) has declared a regular quarterly dividend of $0.43 per common share, payable on November 10, 2020, to shareholders of record on
![U.S. FDA Approves Pfizer’s XELJANZ® (tofacitinib) for the Treatment of Active Polyarticular Course Juvenile Idiopathic Arthritishttp://www.flickr.com/photos/w0ahitslo/6955091156/sizes/z/in/photostream/: All rights reserved by Queen Beuaroo](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBZHc9IiwiZXhwIjpudWxsLCJwdXIiOiJibG9iX2lkIn19--be1a2af5756eaa0acf5414ead3504a7e3ad45f8a/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/Pfizer.jpg?locale=us)
U.S. FDA Approves Pfizer’s XELJANZ® (tofacitinib) for the Treatment of Active Polyarticular Course Juvenile Idiopathic Arthritis
Pfizer Inc. (NYSE: PFE) announced today that the United States (U.S.) Food and Drug Administration (FDA) approved XELJANZ® (tofacitinib) for the treatment of children and adolescents 2 years and
![CalBio, Dairy Farmers and Chevron Announce First RNGhttp://intelligents.wpengine.netdna-cdn.com/wp-content/uploads/2011/04/chevron-corporation-logo.png: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/11090/chevron-corporation-logo.png](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBZWs9IiwiZXhwIjpudWxsLCJwdXIiOiJibG9iX2lkIn19--810d4ee3ee1f323ecd07b89039e6a5fb12ed54d0/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/chevron-corporation-logo.png?locale=us)
CalBio, Dairy Farmers and Chevron Announce First RNG
California Bioenergy LLC (CalBio), Chevron U.S.A. Inc. and local dairy farmers today announced their joint venture, CalBioGas LLC, successfully achieved first renewable natural gas (RNG) production
![Pfizer Declares Fourth-Quarter 2020 Dividendhttp://www.flickr.com/photos/w0ahitslo/6955091156/sizes/z/in/photostream/: All rights reserved by Queen Beuaroo](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBZHc9IiwiZXhwIjpudWxsLCJwdXIiOiJibG9iX2lkIn19--be1a2af5756eaa0acf5414ead3504a7e3ad45f8a/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/Pfizer.jpg?locale=us)
Pfizer Declares Fourth-Quarter 2020 Dividend
The board of directors of Pfizer Inc. (NYSE:PFE) declared a 38-cent fourth-quarter 2020 dividend on the company’s common stock, payable December 1, 2020, to holders of the Common Stock of record at
![FDA Accepts Supplemental New Drug Application for Pfizer’s XALKORI® (crizotinib) for the Treatment of Pediatric ALK-positive Anaplastic Large Cell Lymphoma](/assets/news/news13-125fa69a38b6955d740c18f7e750c42a3317f6873eded3044187d2ece3aa0ac7.png)
FDA Accepts Supplemental New Drug Application for Pfizer’s XALKORI® (crizotinib) for the Treatment of Pediatric ALK-positive Anaplastic Large Cell Lymphoma
Pfizer Inc. (NYSE:PFE) today announced that the U.S. Food and Drug Administration (FDA) has accepted and granted priority review to the Company’s supplemental New Drug Application(sNDA)for XALKORI®
![Nike: Kursfeuerwerk nach bombastischen Quartalszahlen!](/assets/news/news17-d49b9ce9c87babddea210274f0f8d00a1cf706146ef6382020cc7ece83b76f6c.png)
Nike: Kursfeuerwerk nach bombastischen Quartalszahlen!
Zu den größten Gewinnern am US-Aktienmarkt dürfte heute die Aktie des weltgrößten Sportartikelherstellers Nike (WKN: 866993) gehören. Die Aktie zieht damit auch den Auswahlindex Dow Jones, in dem
![NIKE, Inc. Reports Fiscal 2021 First Quarter Results](/assets/news/news7-ff65ae96e2a4b99929975e34f30f51b3393455f312fc86852d9fc8020c5054eb.png)
NIKE, Inc. Reports Fiscal 2021 First Quarter Results
NIKE, Inc. (NYSE:NKE) today reported fiscal 2021 financial results for its first quarter ended August 31, 2020.
-
First quarter reported revenues were $10.6 billion, down 1 percent on a reported
![American Express Plans Live Audio Webcast Of Third-Quarter 2020 Earnings Conference Call](/assets/news/news19-14feaf1b3ac689101974b5354f2ab8bb5cb2e7cb49a06b120b8491e9ebba31f4.png)
American Express Plans Live Audio Webcast Of Third-Quarter 2020 Earnings Conference Call
American Express Company (NYSE: AXP) plans to host a live audio webcast of its earnings conference call at 8:30 a.m. (ET) on Friday, October 23, 2020, to discuss third-quarter 2020 financial